Jazz Pharmaceuticals (JAZZ) News Today $111.30 -0.78 (-0.70%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$111.31 +0.01 (+0.01%) As of 08/8/2025 07:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Jazz Pharmaceuticals Down Today?Toggle Visibility of Why Is Jazz Pharmaceuticals Down Today?Jazz Pharmaceuticals PLC (NASDAQ:JAZZ) Key Drivers Positive Sentiment: FDA grants accelerated approval to Jazz’s Modeyso for H3 K27M-Mutant diffuse midline glioma. FDA Grants Accelerated Approval to Jazz Pharmaceuticals’ Modeyso for H3 K27M-Mutant Diffuse Midline Glioma Positive Sentiment: Chimerix buyout strengthens Jazz’s pipeline with FDA nod for rare glioma drug. Chimerix buyout a win for Jazz with FDA nod for rare glioma drug Positive Sentiment: FDA greenlights Jazz’s Dordaviprone as first new treatment for an ultra-rare brain tumor. FDA Greenlights Jazz’s Dordaviprone, First New Treatment for Ultra-Rare Brain Tumor Positive Sentiment: Retail traders rally on FDA clearance of Jazz’s rare brain tumor drug. Retail Traders Cheer Jazz Pharma After FDA Clears Rare Drug For Brain Tumor Neutral Sentiment: Analysts recommend focusing on Jazz’s international revenue trends to assess stability and growth prospects. Don't Overlook Jazz (JAZZ) International Revenue Trends While Assessing the Stock Neutral Sentiment: BiopharmaDive highlights Jazz’s Modeyso approval in a broader biotech market review. Elevidys sales weaken; Neumora gets into obesity Neutral Sentiment: MMM Online’s Rx Rundown mentions Jazz among key pharma updates. Rx Rundown: Pfizer, SERB Pharmaceuticals, Novo Nordisk and more Neutral Sentiment: Stat News Pharmalittle covers Jazz alongside industry-wide R&D and pipeline news. Pharmalittle: We’re reading about mRNA cancer vaccines, Lilly’s disappointing obesity pill data, and more Neutral Sentiment: Jazz outlines late Q4 zanidatamab Phase III data timing, leadership transition, and updated 2025 guidance. Jazz Pharmaceuticals projects late Q4 zanidatamab Phase III data, signals leadership transition and updates 2025 guidance Neutral Sentiment: Yahoo Finance breaks down the drivers behind Jazz’s stock movement today. Why Jazz Pharmaceuticals (JAZZ) Stock Is Trading Up Today Negative Sentiment: Jazz’s Q2 2025 results missed consensus on EPS, dampening near-term outlook. Jazz Pharmaceuticals Second Quarter 2025 Earnings: EPS Misses Expectations Negative Sentiment: Morgan Stanley cuts Jazz’s price target to $162.00, though maintains an overweight rating. Morgan Stanley Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $162.00 Posted 1+ days agoAI Generated. May Contain Errors. JAZZ Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Measured Wealth Private Client Group LLC Buys New Stake in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 10 at 6:28 AM | marketbeat.comJazz Pharmaceuticals (JAZZ) Receives a Buy from J.P. MorganAugust 9 at 2:26 AM | theglobeandmail.comWhy Jazz Pharmaceuticals (JAZZ) Stock Is Trading Up TodayAugust 8 at 10:03 AM | finance.yahoo.comOntario Teachers Pension Plan Board Has $3.10 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 8 at 6:30 AM | marketbeat.comAXS Investments LLC Invests $670,000 in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 8 at 5:22 AM | marketbeat.comMorgan Stanley Lowers Jazz Pharmaceuticals (NASDAQ:JAZZ) Price Target to $162.00August 7 at 1:46 PM | marketbeat.comJazz Pharmaceuticals Second Quarter 2025 Earnings: EPS Misses ExpectationsAugust 7 at 12:59 PM | finance.yahoo.comRetail Traders Cheer Jazz Pharma After FDA Clears Rare Drug For Brain TumorAugust 7 at 7:59 AM | msn.comJazz Pharmaceuticals projects late Q4 zanidatamab Phase III data, signals leadership transition and updates 2025 guidanceAugust 7 at 7:59 AM | msn.comCM Management LLC Has $2.48 Million Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 7 at 7:11 AM | marketbeat.comNatixis Advisors LLC Purchases 5,259 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 7 at 3:42 AM | marketbeat.comBeyond the Balance Sheet: What SWOT Reveals About Jazz Pharmaceuticals PLC (JAZZ)August 6, 2025 | gurufocus.comJazz Pharmaceuticals (NASDAQ:JAZZ) Issues Quarterly Earnings Results, Misses Expectations By $3.46 EPSAugust 6, 2025 | marketbeat.comJazz Pharmaceuticals (NASDAQ:JAZZ) Updates FY 2025 Earnings GuidanceAugust 6, 2025 | marketbeat.comJazz Pharmaceuticals Announces U.S. FDA Approval of Modeyso™ (dordaviprone) as the First and Only Treatment for Recurrent H3 K27M-mutant Diffuse Midline GliomaAugust 6, 2025 | prnewswire.comUS FDA approves Jazz Pharma's drug for rare brain tumorAugust 6, 2025 | reuters.comJazz Pharmaceuticals plc (JAZZ) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comJazz Pharmaceuticals plc 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comFederated Hermes Inc. Decreases Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 6, 2025 | marketbeat.comWhat To Expect From Elanco’s (ELAN) Q2 EarningsAugust 6, 2025 | finance.yahoo.comJazz Pharmaceuticals PLC (JAZZ) Q2 2025 Earnings Call Highlights: Strong Neuroscience ...August 6, 2025 | gurufocus.comJazz Pharmaceuticals (NASDAQ:JAZZ) Reports Q2 In Line With Expectations But Stock DropsAugust 5, 2025 | finance.yahoo.comJazz Pharmaceuticals misses on Q2 earnings, shares fallAugust 5, 2025 | investing.comJazz Pharmaceuticals Announces Second Quarter 2025 Financial Results and Updates 2025 Financial GuidanceAugust 5, 2025 | prnewswire.comJazz Pharmaceuticals (NASDAQ:JAZZ) investors are sitting on a loss of 25% if they invested three years agoAugust 5, 2025 | finance.yahoo.comJazz Pharmaceuticals (JAZZ) To Report Earnings Tomorrow: Here Is What To ExpectAugust 4, 2025 | msn.comJefferies Financial Group Inc. Buys New Shares in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 4, 2025 | marketbeat.comVestcor Inc Invests $601,000 in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 4, 2025 | marketbeat.comLSV Asset Management Sells 64,884 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 3, 2025 | marketbeat.comArkadios Wealth Advisors Has $1.58 Million Stock Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)August 3, 2025 | marketbeat.comMorgan Stanley Reduces PT on Jazz Pharmaceuticals plc (JAZZ) from $166 to $165; Maintains ‘Buy’ RatingJuly 30, 2025 | finance.yahoo.com2 Growth Stocks Wall Street Predicts Will Soar 74% to 159%July 30, 2025 | finance.yahoo.comJazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Purchased by Zurcher Kantonalbank Zurich CantonalbankJuly 29, 2025 | marketbeat.comJazz Pharmaceuticals PLC (NASDAQ:JAZZ) Shares Sold by Allianz Asset Management GmbHJuly 28, 2025 | marketbeat.comCaliber Wealth Management LLC KS Buys Shares of 2,279 Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 27, 2025 | marketbeat.comPacer Advisors Inc. Sells 1,369,775 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 26, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Makes New Investment in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 26, 2025 | marketbeat.comY Intercept Hong Kong Ltd Raises Stock Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 25, 2025 | marketbeat.comJazz Pharmaceuticals (JAZZ) Expected to Announce Quarterly Earnings on WednesdayJuly 23, 2025 | marketbeat.comJazz Pharmaceuticals price target lowered to $165 from $166 at Morgan StanleyJuly 23, 2025 | msn.comJazz Pharmaceuticals to Report Second Quarter Financial Results on August 5, 2025July 22, 2025 | prnewswire.comMorgan Stanley Has Lowered Expectations for Jazz Pharmaceuticals (NASDAQ:JAZZ) Stock PriceJuly 22, 2025 | marketbeat.comJazz Pharmaceuticals PLC (NASDAQ:JAZZ) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 22, 2025 | marketbeat.comWhy Alkermes Tumbled On Its Positive Narcolepsy StudyJuly 21, 2025 | msn.comAlkermes Offers The Next Proof Point For Its Narcolepsy Approach. Stock Dives.July 21, 2025 | msn.comGW&K Investment Management LLC Boosts Stock Position in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 21, 2025 | marketbeat.comVictory Capital Management Inc. Boosts Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 21, 2025 | marketbeat.comNew York State Common Retirement Fund Trims Stock Holdings in Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 21, 2025 | marketbeat.comFoundry Partners LLC Purchases 81,337 Shares of Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)July 19, 2025 | marketbeat.comJazz Pharmaceuticals PLC (NASDAQ:JAZZ) Stock Position Raised by Envestnet Asset Management Inc.July 19, 2025 | marketbeat.com Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address JAZZ Media Mentions By Week JAZZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. JAZZ News Sentiment▼0.420.48▲Average Medical News Sentiment JAZZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. JAZZ Articles This Week▼3113▲JAZZ Articles Average Week Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AXSM News RPRX News CORT News PRGO News SUPN News PCRX News NKTR News OMER News ASMB News CPIX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:JAZZ) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredI trusted Trump and got screwedPorter Stansberry says he got one thing wrong—and now millions of Americans could pay the price. After warning...Porter & Company | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free JAZZ Stock Alerts